Table: begin end state 1 29 cytoplasmic 30 49 transmembrane 50 55 non-cytoplasmic 56 80 transmembrane 81 89 cytoplasmic 90 111 transmembrane 112 118 non-cytoplasmic 119 144 transmembrane 145 162 cytoplasmic 163 180 transmembrane 181 188 non-cytoplasmic 189 209 transmembrane 210 233 cytoplasmic 234 258 transmembrane 259 277 non-cytoplasmic 278 296 transmembrane 297 306 cytoplasmic 307 327 transmembrane 328 334 non-cytoplasmic 335 358 transmembrane 359 368 cytoplasmic 369 392 transmembrane 393 402 non-cytoplasmic 403 421 transmembrane 422 432 cytoplasmic
Input: >BPHYT_RS27415 MHPSPSTLTPARSKAAAVFRVTAGNFLEQFDFFLFGFYATQIANVFFPAASEFASLMMTF AVFGAGFLMRPLGAIVLGAYIDDVGRRKGLIVTLSIMATGTILIAFVPGYATIGLAAPAL VLIGRLLQGFSAGAELGGVSVYLAEMATPGRKGLFTSWQSASQQVAIVVAAALGFALNQS LDAATIAAWGWRVPFFVGCMIVPFIFMLRRNLQETEEFKARQHRPNMKEVLRTLVENWTV VIAGMMLVAMTTASFYLITVYAPTFGKTVLHLSTADSLLVTLCVAVSNFVWLPIGGALSD RIGRRPLLVAMTLLAILTAYPALSFLAHAPSFVNMLLALLWLSFMYGIYNGAMVVALTEV MPAQVRVAGFSLAYSLATAVFGGFTPAISTALIHMTGDKAAPGYWMSFAAACALLATFAL YRRRAATLTPAH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server